Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)
Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –
Globus Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Globus Medical's profit margin for the twelve months ending Jun 30, 2026 was 17.0%. For fiscal 2025 it was 18.3%, against 4.1% the year before. The highest annual figure on record is 21.9% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.3% | +14.2 |
| FY2024 | Dec 31, 2024 | 4.1% | −3.7 |
| FY2023 | Dec 31, 2023 | 7.8% | −10.8 |
| FY2022 | Dec 31, 2022 | 18.6% | +3.0 |
| FY2021 | Dec 31, 2021 | 15.6% | +2.6 |
| FY2020 | Dec 31, 2020 | 13.0% | −6.8 |
| FY2019 | Dec 31, 2019 | 19.8% | −2.2 |
| FY2018 | Dec 31, 2018 | 21.9% | +5.1 |
| FY2017 | Dec 31, 2017 | 16.9% | −1.6 |
| FY2016 | Dec 31, 2016 | 18.5% | −2.2 |
| FY2015 | Dec 31, 2015 | 20.7% | +1.2 |
| FY2014 | Dec 31, 2014 | 19.5% | +3.7 |
| FY2013 | Dec 31, 2013 | 15.8% | −3.3 |
| FY2012 | Dec 31, 2012 | 19.1% | +0.8 |
| FY2011 | Dec 31, 2011 | 18.3% | −0.6 |
| FY2010 | Dec 31, 2010 | 18.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 19.2% | −8.0 |
| Q1 FY2026 | Mar 31, 2026 | 16.4% | +3.7 |
| Q4 FY2025 | Dec 31, 2025 | 17.0% | +13.0 |
| Q3 FY2025 | Sep 30, 2025 | 15.5% | +7.2 |
| Q2 FY2025 | Jun 30, 2025 | 27.2% | +22.2 |
| Q1 FY2025 | Mar 31, 2025 | 12.6% | +13.8 |
| Q4 FY2024 | Dec 31, 2024 | 4.0% | +1.6 |
| Q3 FY2024 | Sep 30, 2024 | 8.3% | +8.0 |
| Q2 FY2024 | Jun 30, 2024 | 5.0% | −14.7 |
| Q1 FY2024 | Mar 31, 2024 | -1.2% | −18.9 |
| Q4 FY2023 | Dec 31, 2023 | 2.4% | −15.8 |
| Q3 FY2023 | Sep 30, 2023 | 0.3% | −18.4 |
| Q2 FY2023 | Jun 30, 2023 | 19.8% | −0.9 |
| Q1 FY2023 | Mar 31, 2023 | 17.8% | +1.2 |
| Q4 FY2022 | Dec 31, 2022 | 18.2% | +12.2 |
| Q3 FY2022 | Sep 30, 2022 | 18.7% | −1.9 |
| Q2 FY2022 | Jun 30, 2022 | 20.7% | +4.2 |
| Q1 FY2022 | Mar 31, 2022 | 16.5% | −3.4 |
| Q4 FY2021 | Dec 31, 2021 | 6.0% | −16.6 |
| Q3 FY2021 | Sep 30, 2021 | 20.6% | +0.1 |
| Q2 FY2021 | Jun 30, 2021 | 16.6% | +30.5 |
| Q1 FY2021 | Mar 31, 2021 | 19.9% | +6.3 |
| Q4 FY2020 | Dec 31, 2020 | 22.7% | +1.2 |
| Q3 FY2020 | Sep 30, 2020 | 20.5% | +0.9 |
| Q2 FY2020 | Jun 30, 2020 | -14.0% | −33.6 |
| Q1 FY2020 | Mar 31, 2020 | 13.6% | −4.5 |
| Q4 FY2019 | Dec 31, 2019 | 21.5% | +2.8 |
| Q3 FY2019 | Sep 30, 2019 | 19.5% | −1.3 |
| Q2 FY2019 | Jun 30, 2019 | 19.6% | −6.3 |
| Q1 FY2019 | Mar 31, 2019 | 18.2% | −4.5 |
| Q4 FY2018 | Dec 31, 2018 | 18.8% | +4.9 |
| Q3 FY2018 | Sep 30, 2018 | 20.8% | +3.9 |
| Q2 FY2018 | Jun 30, 2018 | 25.9% | +7.1 |
| Q1 FY2018 | Mar 31, 2018 | 22.7% | +4.2 |
| Q4 FY2017 | Dec 31, 2017 | 13.8% | −2.2 |
| Q3 FY2017 | Sep 30, 2017 | 16.9% | −2.5 |
| Q2 FY2017 | Jun 30, 2017 | 18.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 18.4% | – |
| Q4 FY2016 | Dec 31, 2016 | 16.0% | – |
| Q3 FY2016 | Sep 30, 2016 | 19.3% | – |
See a number that looks wrong?